ArticleMolecular plant pathology2026
ZmNPSN13 Potentiates Maize Rough Dwarf Disease Upon Recruitment by the RBSDV P7-1 Effector.
Article in Molecular plant pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Maize rough dwarf disease (MRDD), caused by fijiviruses, poses a major threat to global maize production, with rice black-streaked dwarf virus (RBSDV) being the predominant pathogen in Asia. The viral effector P7-1 initiates MRDD by hijacking the host susceptibility factor ZmGDIα, while its reduced affinity for the helitron-inserted variant ZmGDIα-hel underlies recessive resistance. Here, we identified the Qb-SNARE protein ZmNPSN13 as a novel host target of P7-1. ZmNPSN13 functions as a central hub, interacting with both ZmGDIα and the gibberellin-inactivating enzyme ZmGA2ox7.3. During infection, P7-1 recruits these host components into a pathogenic complex that disrupts phytohormone homeostasis, thereby driving MRDD development. Notably, knockout of ZmNPSN13 restored hormonal balance and enhanced viral resistance comparable to that achieved by replacing ZmGDIα with ZmGDIα-hel. Our work uncovers a mechanism by which a virus exploits SNARE-mediated vesicle trafficking to subvert host immunity, establishing ZmNPSN13 as a promising target for engineering MRDD-resistant maize cultivars.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.